Zalunfiban, a glycoprotein IIb/IIIa inhibitor specifically formulated for rapid subcutaneous administration, has been ...

Background Primary percutaneous coronary intervention (PCI) has significantly improved outcomes for ST-segment elevation ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

With new phase 3 data backing the ability of its emergency use zalunfiban to fend off further heart damage, CeleCor ...

Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex ...

A study was conducted to examine the predictive performance of an AI ECG algorithm for identifying occlusive myocardial infarction.

Compared with the standard of care, an AI-based ECG model greatly reduced false positives for ST-elevation myocardial infarction, according to findings presented at TCT 2025.The model also ...

Patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective ...